(Q43963777)

English

Less intense conditioning with fludarabine, cyclophosphamide, idarubicin and etoposide (FCIE) followed by allogeneic unselected peripheral blood stem cell transplantation in elderly patients with leukemia

scientific article published in April 2002

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Less intense conditioning with fludarabine, cyclophosphamide, idarubicin and etoposide (FCIE) followed by allogeneic unselected peripheral blood stem cell transplantation in elderly patients with leukemia (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Schlenk RF

1

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Hartmann F

2

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Hensel M

3

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Jung W

4

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Weber-Nordt R

5

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Gabler A

6

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Haas R

7

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Ho AD

8

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Trümper L

9

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Döhner H

10

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 April 2002

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

16

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

581-586

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

How does bone-marrow transplantation cure leukaemia?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402423

7 January 2021

based on heuristic

inferred from DOI database lookup

Graft-versus-host disease as adoptive immunotherapy in patients with advanced hematologic neoplasms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402423

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome after allogeneic bone marrow transplant for leukemia in older adults

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402423

7 January 2021

based on heuristic

inferred from DOI database lookup

Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402423

7 January 2021

based on heuristic

inferred from DOI database lookup

Detection of chimerism and early engraftment after allogeneic peripheral blood stem cell or bone marrow transplantation by short tandem repeats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402423

7 January 2021

based on heuristic

inferred from DOI database lookup

Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402423

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402423

7 January 2021

based on heuristic

inferred from DOI database lookup

Censoring distributions as a measure of follow-up in survival analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402423

7 January 2021

based on heuristic

inferred from DOI database lookup

A controlled study of recombinant human granulocyte colony-stimulating factor in elderly patients after treatment for acute myelogenous leukemia. AML Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402423

7 January 2021

based on heuristic

inferred from DOI database lookup

Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia. Cancer and Leukemia Group B.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402423

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term survival in acute myelogenous leukemia: a second follow-up of the Fourth International Workshop on Chromosomes in Leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402423

7 January 2021

based on heuristic

inferred from DOI database lookup

Age-related incidence and other epidemiological aspects of myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402423

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic bone marrow transplantation as therapy for primary induction failure for patients with acute leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402423

7 January 2021

based on heuristic

inferred from DOI database lookup

Mini-allografts: ongoing trials in humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402423

7 January 2021

based on heuristic

inferred from DOI database lookup

Metabolism and action of purine nucleoside analogs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402423

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402423

7 January 2021

based on heuristic

inferred from DOI database lookup

Rhenium 188-labeled anti-CD66 (a, b, c, e) monoclonal antibody to intensify the conditioning regimen prior to stem cell transplantation for patients with high-risk acute myeloid leukemia or myelodysplastic syndrome: results of a phase I-II study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402423

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.LEU.2402423

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43963777&oldid=2206361371"